I CARE study
colon carcinoma, cancer, cancers, fits
CANCERS, RECURRENCE, CANCER, RECRUITMENT, SECOND CANCERS, COLON CARCINOMA
The I CARE study is a multi-centre 2 × 2 factorial randomised controlled trial comparing GP-led with surgeon-led (usual) survivorship care for limited-stage (I, II, and III) patients with colon carcinoma in which Eight Dutch hospitals participated. Patients were also randomised for access to ‘Oncokompas’, a supporting eHealth application that aims to increase patient knowledge on cancer and facilitate access to supportive care. The primary outcome was QoL. A full description of the study procedures and recruitment period have been previously published.I CARE interventionprevention of recurrent and new cancers, and of other late effects;surveillance for cancer spread, recurrence, or second cancers; assessment of medical and psychosocial late effects;intervention for consequences of cancer and its treatment; andcoordination between specialists and primary care providers to ensure that all of the survivor’s health needs are met.How this fits in